European Companies Search Engine

EU funding (€11.7M): bridGing gaps in caRdiAC health managEment Hor1 Feb 2025 EU Research and Innovation programme "Horizon"

Overview

Text

bridGing gaps in caRdiAC health managEment

The GRACE integrated solution aims to transform the healthcare ecosystem by providing essential knowledge and innovative public-private partnership for (1) reorganizing healthcare services (2) with embedded innovative technologies and tools, helping identifying and overcoming barriers and gaps that are now hindering CVD management, ensuring a seamless continuum of care and optimized care pathways. Our vision is that introducing effective health technology and interventions is economically, societally and environmentally sustainable if and only accompanied by a substantial healthcare service re-organization. Accordingly, GRACE will focus on an end-to-end clinical pathway CVD, considering an holistic view of the patient and optimizing healthcare services leveraging on advanced technological solutions. GRACE intervention will be multifold aiming at: (1) guiding strategic policies, (2) drive market innovation, and (3) foster effective healthcare delivery practices in CVD, generating value for patients, healthcare workers and system. GRACE will enable early and personalized interventions, fostering coordination of multidiscipline healthcare teams, triggering more intense and person-specific management using innovative technologies, AI and digital solutions for early detection of red flags, promoting patient empowerment, while comprehensively containing CVD risk factors and burden. A multidisciplinary consortium of experienced and competitive partners will implement this vision and implement the proposed solution in a novel multidiscipline manner.


Funded Companies:

Company name Funding amount
Samsung Electronics ?
Active Ageing Association €350,000
Astrazeneca Farmaceutica Spain SA €0.00
BRIDG OÜ €335,000
Centre Hospitalier Universitaire de Rennes €426,188
Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) €405,625
Dedalus Italia S.p.A. €957,395
Ethniko Kentro Erevnas Kai Technologikis Anaptyxis €102,228
Fondazione Policlinico Universitario Agostino Gemelli Irccs €304,000
Fondazione Policlinico Universitario Campus BIO Medico €100,250
Fundacion para La Investigacion Biosanitaria de Andalucia Oriental-Alejandro Otero €348,750
Happy Mondays Communication SL €335,000
Human Factor & Innovation SRL Start-UP €70,000
Institut Catala de La Salut €340,460
Medtronic France €435,533
Medtronic Iberica SA €1,610,500
Outcomes'10 SL €106,625
PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. €1,696,400
PHILIPS MEDICAL SYSTEMS TECHNOLOGIES Ltd. €640,000
Predictby Research And Consulting SL €254,500
Samsung Electronics (UK) Ltd. €1,179,250
Servicio Madrileno de Salud €401,500
Universita Campus BIO Medico Di Roma €435,250
UNIVERSITAIR MEDISCH CENTRUM UTRECHT €392,475
UNIVERSITATSKLINIKUM BONN €314,375
WAVY ASSISTANT B.V. €195,000

Source: https://cordis.europa.eu/project/id/101194778

The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Samsung Electronics.

Creative Commons License The visualizations for "Samsung Electronics - EU funding (€11.7M): bridGing gaps in caRdiAC health managEment" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.